5-HT1B antagonists (Roche/GW/Astra/Tripos)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT1B antagonists (Roche/GW/Astra/Tripos)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor antagonists
TargetsSerotonin 1b (5-HT1b) receptor
Therapy Area/IndicationsRaynaud DiseaseAngina PectorisCardiovascular Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Palo Alto Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTripos IncAstrazeneca Uk LtdGlaxo Group Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsRaynaud DiseaseAngina PectorisCardiovascular Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A